LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
40 hedge funds and large institutions have $120M invested in Landos Biopharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
12
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
OMC
1
OUP Management Company
Bala Cynwyd,
Pennsylvania
|
$8.77M |
2 |
2
BlackRock
New York
|
$2.26M |
3 |
3
Renaissance Technologies
New York
|
$821K |
4 |
4
Morgan Stanley
New York
|
$738K |
5 |
5
Walleye Capital
New York
|
$505K |